Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Appointed director
TransMedics Group, Inc. (TMDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"TransMedics Completes Acquisition of Summit Aviation Andover, Mass. - August 16, 2023 - TransMedics Group, Inc. , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the closing of its previously announced acquisition of Summit Aviation, a premier U.S. charter flight operator. The acquisition enables the establishment of TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the U.S. “We are delighted to complete the acquisition of Summit Aviation, which represents a critical element of TransMedics' strategy to build and manage a national transplant logistics network designed to expand the reach and coverage of the Nat..."
08/03/2023 8-K Quarterly results
Docs: "TransMedics Group, Inc.CONSOLIDATED STATEMENTS OF OPERATIONS"
06/29/2023 8-K Credit agreement amendment
Docs: "Second Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent",
"Second Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent"
05/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan"
05/11/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, by and between TransMedics Group, Inc. and U.S. Bank Trust Company, National Association (including the form of the 1.50% Convertible Senior Note due 2028)",
"Purchase Agreement, among TransMedics Group, Inc. and the several Initial Purchasers named in Schedule 1 thereto for whom Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC acted as Representatives",
"Form of Call Option Transaction Confirmation"
05/09/2023 8-K Credit agreement amendment
Docs: "First Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lender party thereto and Canadian Imperial Bank of Commerce, as administrative agent",
"First Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lender party thereto and Canadian Imperial Bank of Commerce, as administrative agent"
05/01/2023 8-K Quarterly results
Docs: "TransMedics Group, Inc.CONSOLIDATED STATEMENTS OF OPERATIONS"
02/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Restricted Stock Unit Award",
"Form of Inducement Restricted Stock Unit Award"
02/22/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "TransMedics Group, Inc.CONSOLIDATED STATEMENTS OF OPERATIONS"
11/04/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
08/01/2022 8-K Quarterly results
Docs: "TransMedics Reports Second Quarter 2022 Financial Results Accelerated Commercial Momentum to Achieve Net Revenue of $20.5 million 2022 Revenue Guidance Range Raised to $67 million to $75 million"
07/29/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Credit Agreement, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent and collateral agent",
"Guarantee and Collateral Agreement, by and among TransMedics Group, Inc., TransMedics, Inc., TransMedics B.V. and Canadian Imperial Bank of Commerce"
06/02/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
02/23/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results"
09/29/2021 8-K Quarterly results
09/07/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
07/15/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : July 14, 2021 TransMedics Group, Inc. Massachusetts 001-38891 83-2181531 200 Minuteman Road Andover, Massachusetts 01810 552-0900 Registrant's Telephone Number, Including Area Code",
"TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System"
05/28/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
04/07/2021 8-K Quarterly results
03/24/2021 8-K Quarterly results
03/02/2021 8-K Quarterly results
12/23/2020 8-K Appointed a new director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : December 17, 2020 TransMedics Group, Inc. Massachusetts 001-38891 83-2181531 200 Minuteman Road Andover, Massachusetts 01810 552-0900 Registrant's Telephone Number, Including Area Code"
11/04/2020 8-K Quarterly results
Docs: "TransMedics Reports Third Quarter 2020 Financial Results"
08/05/2020 8-K Quarterly results
06/08/2020 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 4, 2020 TransMedics Group, Inc. Massachusetts 001-38891 83-2181531 200 Minuteman Road Andover, Massachusetts 01810 552-0900 Registrant's Telephone Number, Including Area Code Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ P..."
06/05/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Opinion of Ropes & Gray LLP",
"Opinion of Ropes & Gray LLP"
06/02/2020 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : June 1, 2020 TransMedics Group, Inc. Massachusetts 001-38891 83-2181531 200 Minuteman Road Andover, Massachusetts 01810 552-0900 Registrant's Telephone Number, Including Area Code"
05/28/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 26, 2020 TransMedics Group, Inc. Massachusetts 001-38891 83-2181531 200 Minuteman Road Andover, Massachusetts 01810 552-0900 Registrant's Telephone Number, Including Area Code Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ P...",
"Underwriting Agreement, by and among the Company and J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters named in Schedule I thereto",
"Opinion of Ropes & Gray LLP"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy